Anadys Pharmaceuticals Inc. (NASDAQ: ANDS) is trading 8,000 calls, 20-times average, as the March $2.50/$5.00 call spread is bought for 4,000 contracts at a $0.35 cost with shares at $2.35. Shares looked to have carved out a higher low here and are bouncing today, 5.4% higher. Anadys has seen its Hepatitis C drug meet key goals in recent trials and shares trade 3.3X cash value, and may be set for a partnership.
Shares of Anadys are up 5% at $2.35 on about 450,000 shares as of NOON EST. The 52-week trading range is $1.44 to $8.43 and the average daily volume in the stock is only about 600,000 shares.
JON C. OGG
